StockData
Baxter International Inc logo

Baxter International Inc

BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/306% above fair value
$26.16+0.40 (+1.55%)

Close on Nov 18, 2026Market cap $13.53BP/E –Yield 1.99%

Baxter International ClinicalTrials.gov Sponsored Clinical Studies Started by Year

Baxter International ClinicalTrials.gov Sponsored Clinical Studies Started: 8 in 2025, down 33.3% from a year earlier. That is the lowest of the 10 years on record here.

Latest, 2025
8
Period ended Dec 31, 2025
Change on a year earlier
-33.3%
12 in 2024
History
10 years
Since 2016
Sources
1
ClinicalTrials.gov Registry API v2 (Sponsor: Baxter Healthcare)

Where the 2025 figure comes from

Source: ClinicalTrials.gov Registry API v2 (Sponsor: Baxter Healthcare) ↗

Registered clinical studies sponsored by Baxter Healthcare by study start date

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Breakdown

What makes up clinicalTrials.gov Sponsored Clinical Studies Started

Cite this data

StockData. (2026). Baxter International ClinicalTrials.gov Sponsored Clinical Studies Started, annual 2016–2025 [Data set]. Compiled from Baxter International SEC filings and investor materials. https://stockdatahq.com/stocks/bax/kpis/ct-studies-started

See every metric in the Baxter International KPI table. Data updated Nov 18, 2026.

See a number that looks wrong?